Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study | Zendy

Jason Misurac | Zendy; René G. VanDeVoorde | Zendy; Mahmoud Kallash | Zendy; Franca M. Iorember | Zendy; Kera E. Luckritz | Zendy; Michelle N. Rheault | Zendy; Jennifer G. Jetton | Zendy; Martin A. Turman | Zendy; Gaurav Kapur | Zendy; Katherine Twombley | Zendy; Shireen Hashmat | Zendy; Donald J. Weaver | Zendy; Jeffrey Leiser | Zendy; Coriilescu | Zendy

Open Access

Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study

Author(s) -

Jason Misurac,

René G. VanDeVoorde,

Mahmoud Kallash,

Franca M. Iorember,

Kera E. Luckritz,

Michelle N. Rheault,

Jennifer G. Jetton,

Martin A. Turman,

Gaurav Kapur,

Katherine Twombley,

Shireen Hashmat,

Donald J. Weaver,

Jeffrey Leiser,

Coriilescu

Publication year - 2017

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04750416

Subject(s) - medicine , immunogenicity , nephrology , dialysis , intensive care medicine , virology , pediatrics , immunology , antibody

Patients on maintenance dialysis have a higher risk of unresponsiveness to hepatitis B vaccination and loss of hepatitis B immunity. Adult guidelines recommend augmented dosing (40 mcg/dose), resulting in improved response in adults. We sought to determine whether children on dialysis mount a similar antibody response when given standard or augmented dosing of hepatitis B vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research